VenoStent Embarks on Clinical Trial to Improve Success Rate of Vascular Surgery Outcomes
Tim Boire, CEO said, “After years of development, we are confident that our bioabsorbable wrap technology can have a positive impact on the lives of patients that require hemodialysis to sustain life.